Audubon Bioscience
- Company typePrivate
- Founded2016
- HeadquartersHouston, United States
- Headcount51–100
- GTM typeB2B
- OfferingServices
Audubon Bioscience firmographics
Firmographics- Name
- Audubon Bioscience
- Legal name
- Audubon Bioscience Co
- Website
- https://audubonbio.com
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Ownership category
- akta.pro rank
Audubon Bioscience industry classification
Industry- Product category
- Biospecimen Procurement and Biobanking Services
- NAICS
- Scientific Research and Development Services (5417), Medical Laboratories (621511)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Clinical Trial Sample Collection & Site Phlebotomy Services (HLAGACAJ)
- akta.pro secondary industries
- Clinical CROs (Phase I–IV) (HLAGAAAA), Central Laboratory & Clinical Trial Testing CROs (HLAGAAAE)
Keywords
Where Audubon Bioscience is headquartered
LocationHeadquarters
- HQ city
- Houston
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Audubon Bioscience business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Supply Chain, Personnel, Operations, Infrastructure, Marketing or Sales, Technology or R&D, Others
Revenue model
- Biospecimen sales and procurement services: Audubon Bioscience generates revenue through the sale of human biospecimens (tissues, blood products, cells, biofluids) and associated clinical data. They also offer prospective collection services and CRO services supporting biomedical research. Revenue is derived from transaction-based specimen sales and custom collection project fees.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels4 records
Audubon Bioscience product offering
Product offeringCore offering
Audubon Bioscience is a biobank and biospecimen procurement company that supplies human-derived biological samples — including fresh, FFPE, and frozen tissues; peripheral blood products (whole blood, serum, plasma); cell products (PBMCs, BMMCs, dissociated tumor cells); and biofluids — to academic researchers, biotechnology firms, and pharmaceutical companies. The company operates a global network of 120+ clinical sites across 10 countries and offers prospective collection studies, custom matched sets, and CRO services backed by a quality guarantee.
Product overview
Audubon Bioscience is a biospecimen procurement and biobanking company offering a comprehensive portfolio of human-derived biological samples for biomedical research. The core product offerings span four main categories: Tissues (fresh, FFPE, and frozen), Peripheral Blood Products (whole blood, serum, plasma), Cell Products (PBMCs, BMMCs), and Biofluids (bone marrow, urine, CSF, synovial fluid, saliva, BAL). Additional offerings include Custom Matched Sets combining multiple sample types from the same donor, and Biobank/CRO Services for prospective study support. The company operates a global network of over 120 clinical sites across 10 countries and 4 continents to source ethically-compliant biospecimens with extensive clinical data annotations, supporting cancer research, biomarker discovery, and precision medicine development.
Differentiator
Problem solved
Functional benefit
Products and services
- Tissues (Fresh, FFPE, Fresh Frozen) Provides fresh, FFPE (Formalin-Fixed Paraffin-Embedded), and flash-frozen tissue samples from donors with various diseases or healthy tissue for biomedical research in oncology, genomics, and morphological analysis.
- Peripheral Blood Products (Whole Blood, Serum, Plasma) Comprehensive peripheral blood-derived products including whole blood, serum, and plasma for biomarker research, liquid biopsy development, genetic screening, and diagnostics.
- Cell Products (PBMCs, BMMCs, Custom Cell Isolations) Isolated cell products including PBMCs (T cells, B cells, NK cells, monocytes), BMMCs, and dissociated tumor cells from healthy and disease-state donors for immuno-oncology, cell-based therapy, and hematological research.
- Biofluids Collection of various biofluids including bone marrow, urine, synovial fluid, CSF, saliva, bronchoalveolar lavage, and ocular fluids for biomarker and diagnostic research.
- Custom Matched Sets Matched biospecimen sets combining solid tissue with liquid biopsy samples (blood components) from the same donor, enabling comprehensive research across multiple sample types.
- Biobank and CRO Services Prospective study support and biorepository management services including IRB approvals, informed consent handling, sample collection logistics, and quality control for biospecimen research.
Quantifiable outcome
- Quality guarantee — free replacement service if delivery does not meet satisfaction
Companies that use Audubon Bioscience
Customer profileSegments3 records
Ideal customer profiles3 records
Audubon Bioscience technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Audubon Bioscience partnerships and signals
Strategic signalScale indicators3 records
Recent moves6 records
Expansion highlights5 records
Audubon Bioscience competitors and assessment
Company assessmentDirect peers
- BioIVT: BioIVT is a leading global supplier of biospecimens, including fresh and frozen tissues, biofluids, and cells, serving pharmaceutical and academic researchers. It is the most direct comparable to Audubon's biobanking and biospecimen procurement model.
- Indivumed: Indivumed operates a global network of clinical sites to procure high-quality, clinically annotated biospecimens for oncology and biomarker research. Direct overlap with Audubon in prospective collection, FFPE/frozen tissue, and multi-region clinical site operations.
- BioChain Institute: BioChain provides FFPE and frozen tissue samples, blood products, and nucleic acids to research customers. Overlaps with Audubon's tissue, blood, and biobank offerings for translational and genomic research.
- Cureline: Cureline is a clinical biobank and CRO specializing in human biospecimens from Eastern European and post-Soviet geographies, serving pharma and biotech. Highly comparable given overlapping clinical site footprint in Ukraine, Moldova, Georgia, and Eastern Europe.
- Boca Biolistics: Boca Biolistics provides human biospecimens including tissues, blood, and biofluids to research customers. Operates as a direct peer in the biobank and biospecimen procurement space with overlapping customer segments.
- ProteoGenex: ProteoGenex provides human tissue samples including fresh frozen, FFPE, and biofluid specimens with detailed clinical data for translational research and biomarker discovery. Comparable offering set to Audubon's tissue-focused portfolio.
- AMSBIO: AMSBIO supplies biological specimens, primary cells, and biospecimen services to life science researchers globally. Overlaps with Audubon in tissues, primary cells (including PBMCs), and biofluids for research applications.
- Geneticist: Geneticist (formerly Conversant Bio) supplies human biospecimens including PBMCs, whole blood, and tissue samples to research customers. Comparable direct competitor in cell products and biobanking.
Emerging players
- iSpecimen: iSpecimen operates a marketplace platform connecting researchers with biospecimen suppliers globally. While its technology-enabled marketplace model differs from Audubon's direct biobank operations, it competes for the same pharma and academic biospecimen procurement dollars.
Broad incumbents
- Reprocell: Reprocell provides a broader portfolio of products and services including biospecimens, iPSCs, cell lines, and contract research services. Larger and more diversified player with overlapping biospecimen and cell product offerings to Audubon's cell products and biobank business.
Market position
Strengths4 records
Weaknesses1 record
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Audubon Bioscience social profiles
Digital presenceAudubon Bioscience financial estimates
Financial estimateRevenue estimate
Valuation estimate
Audubon Bioscience leadership team
Management profileNumber of profiles
Audubon Bioscience funding detail
Funding detailFunding overview
Funding rounds1 record
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Audubon Bioscience M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Audubon Bioscience
What does Audubon Bioscience do?
Audubon Bioscience is a biobank and biospecimen procurement company that supplies human-derived biological samples — including fresh, FFPE, and frozen tissues; peripheral blood products (whole blood, serum, plasma); cell products (PBMCs, BMMCs, dissociated tumor cells); and biofluids — to academic researchers, biotechnology firms, and pharmaceutical companies. The company operates a global network of 120+ clinical sites across 10 countries and offers prospective collection studies, custom matched sets, and CRO services backed by a quality guarantee.
Is Audubon Bioscience a public or private company?
Audubon Bioscience is a private company. It is classified as unknown and is currently operating.
When was Audubon Bioscience founded?
Audubon Bioscience was founded in 2016. It employs 51 to 100 people.
Where is Audubon Bioscience based?
Audubon Bioscience is headquartered in Houston, United States, in the North America region.
How does Audubon Bioscience make money?
One revenue line is on record: biospecimen sales and procurement services.
Who are Audubon Bioscience's main competitors?
Direct peers on record are BioIVT, Indivumed, BioChain Institute, Cureline, Boca Biolistics, ProteoGenex, AMSBIO and Geneticist. iSpecimen is listed as an emerging player. Reprocell is listed as a broad incumbent.
Does Audubon Bioscience have an API?
No public API is recorded for Audubon Bioscience.
What industry is Audubon Bioscience in?
Audubon Bioscience's product category is Biospecimen Procurement and Biobanking Services. Its primary akta.pro industry code is HLAGACAJ, Clinical Trial Sample Collection & Site Phlebotomy Services, with a secondary code of HLAGAAAA, Clinical CROs (Phase I–IV). Its NAICS code is 5417 and its SIC code is 8731.